drugset / Trial / NCT01992614
A Single Dose Study Of PF-06678552 In Healthy Subjects
RandomizedCrossoverTriple-blindBasic science
Summary
PF-06678552 is a new compound proposed for the treatment of hypercholesteremia. The primary purpose of this study is to evaluate the safety and tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of PF-06678552 in healthy subjects.
Timeline
- Start
- 2013-12
- Primary completion
- 2014-03
- Completion
- 2014-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-06678552 | Unknown | — | Oral |
Indications
No indication recorded.